USMJ Develops Plan To Add Potential $20 Million In Sales On Top Of Ecommerce Sales

Rhea-AI Summary

North American Cannabis Holdings (OTC Pink: USMJ) announced plans to potentially generate an additional $20 million in sales through the cultivation of adult-use marijuana and the revitalization of its CBD sports nutrition beverage, EVERx. USMJ has confirmed eligibility for a new adult-use marijuana cultivation license in New York due to recent legislation that allows existing hemp businesses to apply. The company plans to share further details during a shareholder update on March 29.

Positive

• Potential to generate an additional $20 million in sales over the next two years.
• Confirmed eligibility for a new adult-use marijuana cultivation license in New York.
• Successful relaunch of the EVERx CBD Sports Nutrition Beverage at a major event.

Negative

• None.

Dallas, Texas, March 23, 2022 (GLOBE NEWSWIRE) -- North American Cannabis Holdings, Inc. (OTC Pink: USMJ) today announced the company has developed a plan to that could add $20 million in sales on top of the company’s growing sales from its expanding ecommerce business.

The plan is to take advantage or the unexcepted opportunity to grow and sell adult use marijuana in addition to also rapidly capturing the opportunity for USMJ’s recently acquired CBD sports nutrition beverage.

USMJ has recently confirmed its eligibility to apply for the new adult-use marijuana cultivation license recently passed into law in the State of New York.

In February, New York passed a new law to provide provisional marijuana cultivation licenses to existing hemp businesses. 

USMJ has a subsidiary that has been growing hemp for CBD for the past four years.  The subsidiary has received an invitation from the New York Office of Cannabis Management (OCM) to apply for the provisional adult-use cannabis license.

USMJ also recently relaunched the EVERx CBD Sports Nutrition Beverage after acquiring the product line from Puration, Inc. (OTC Pink: PURA) in exchange for a royalty agreement as part of an overall reorganization executed by the co-controlling parent company of USMJ, PURA and Priority Aviation, Inc. (OTC Pink: PJET).

The EVERx CBD Sports Nutrition Beverage relaunch took place at Arnold Schwarzenegger’s annual Arnold Sports Festival.

Between the EVERx and adult use marijuana opportunities, USMJ has developed a plan that it believes can generate a potential $20 million in sales over the next two years separate from the sales that can be generated from the company’s expanding ecommerce business.

USMJ management plans to reveal highlights of the plan next week in a shareholder update scheduled for Tuesday, March 29^th.

USMJ is founded on the core belief that cannabis makes people's lives better. Cannabis can fight disease, improve wellness and do so in an environmentally sustainable manner. North American Cannabis Holdings is dedicated to finding the best possible applications for cannabis to serve consumers. The Company operates USMJ.com and is dedicated to Ongoing Cannabis Consumer Product Development that it can incubate into Future Spin-offs.

USMJ has one spin-off and dividend issuance so far in its cannabis incubation operational history having issued shares of Puration, Inc. (OTC Pink: PURA) in the past. USMJ continues to work closely with PURA and recently acquired a CBD sports nutrition beverage product from PURA in a royalty agreement. The EVERx CBD Sports Nutrition Beverage acquired by USMJ is bottled by Alkame Holdings, Inc. (OTC Pink: ALKM).

Visit the company’s ecommerce site now and bookmark the site to watch for more coming announcements and updates: www.USMJ.com

Contact:
USMJ
Steven Rash
info@aciconglomerated.com
+1 (800) 861-1350

Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

FAQ

What is the plan announced by USMJ on March 23, 2022?

USMJ announced a plan to add $20 million in sales through adult-use marijuana cultivation and a revived CBD sports nutrition beverage.

When is USMJ's next shareholder update scheduled?

The next shareholder update is scheduled for March 29, 2022.

What is the significance of the new law passed in New York for USMJ?

The new law allows USMJ to apply for a provisional adult-use marijuana cultivation license as an existing hemp business.

How does USMJ plan to utilize the EVERx CBD Sports Nutrition Beverage?

USMJ plans to capitalize on the relaunch of EVERx to boost sales alongside their adult-use marijuana opportunities.